CardioZen SRL
CardioZen reported total assets of 329,632 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026).
The score of CardioZen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -40 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CardioZen's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 114,150 € | ||||
| Equity | 95,536 € | ||||
| Cash | 87,700 € | ||||
| EBITDA | 226,522 € | ||||
| Total assets | 329,632 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 13 Aug 2025
- Year ended 31 Dec 2023filed on 02 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 03 May 2022
CardioZen's financial analysis
- Solvency29.0%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CardioZen
CardioZen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0718.894.120
- VAT number
- BE0718894120
- Peppol
- Registered · 0208:0718894120 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jan 2019
- Registered office
- 1390 Grez-Doiceau
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Medical specialists activities (NACE 86220)
CardioZen (SRL) has been based in Grez-Doiceau since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 114,150 € and equity of 95,536 €; its revenue is not published. Its solvency stands at 29.0%, below the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to CardioZen
Companies in the same business, of comparable size and area, outside its group.
- Mephydoc Medical specialists activities Braine-l'Alleud · balance sheet 329,701 €
- Docteur Pascal NAGYPAL Medical specialists activities Dour · balance sheet 332,158 €
- Société Médicale Docteur Ariane Bertholet Medical specialists activities Mons · balance sheet 332,906 €
- Dr. Kevin Van Wallendael psychiater Medical specialists activities Ghent · balance sheet 329,550 €
- Dr. Barbara Veys Medical specialists activities Bruges · balance sheet 329,491 €
- Cabinet d'Orthopedie Stainier Medical specialists activities Lobbes · balance sheet 329,490 €
- Dr Anthony Flandroy Chirurgie Plastique Medical specialists activities Braine-le-Comte · balance sheet 329,406 €
- Dr. PJH Medical specialists activities Vosselaar · balance sheet 329,940 €
Frequently asked questions about CardioZen
What is the revenue of CardioZen?
CardioZen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CardioZen?
In Belgium, the VAT number is the company number prefixed with BE: BE0718894120 for CardioZen, if the company is VAT-registered. Its company number (CBE) is 0718.894.120.
Where is the registered office of CardioZen?
According to the CBE register, the registered office of CardioZen is in 1390 Grez-Doiceau.
What is the equity of CardioZen?
At the close of the 2025 financial year, the equity of CardioZen amounts to 95,536 €, a solvency of 29.0% of total assets.
Who manages CardioZen?
The register lists 1 active mandates at CardioZen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CardioZen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →